Insys Therapeutics Reviews

2.3
Rating Trends
Recommend to a friend
Approve of CEO
(no image)
Michael L. Babich
3 Ratings
  • manager

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Current Employee - Manager in Chandler, AZ
    Current Employee - Manager in Chandler, AZ

    I have been working at Insys Therapeutics

    Recommends
    Positive Outlook
    Approves of CEO
    Recommends
    Positive Outlook
    Approves of CEO

    Pros

    fast growing company excellent package

    Cons

    growing pain and overloaded employees

    Advice to Management

    Keep it up


Insys Therapeutics Interviews

Interview Experience

Interview Experience

50%
0%
50%

Getting an Interview

Getting an Interview

100%

Interview Difficulty

3.5
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Analytical Scientist Interview

    Anonymous Interview Candidate in Chandler, AZ
    Accepted Offer
    Positive Experience
    Average Interview

    Application

    I applied online. The process took 1 dayinterviewed at Insys Therapeutics (Chandler, AZ) in August 2014.

    Interview

    I had an initial phone screen interview, followed by an in-person interview. I interviewed with managers and had a panel interview with scientists. The panel interview was helpful because I got to ask a lot of questions and learn about how things are like in the lab. The whole interview process was very smooth and efficient.

    Interview Questions

    • Have you worked in a deadline-driven environment?   1 Answer

Insys Therapeutics Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.insysrx.com
Headquarters Chandler, AZ
Size 150 to 499 Employees
Founded Unknown
Type Company - Public (INSY)
Industry Biotech & Pharmaceuticals
Revenue $50 to $100 million (USD) per year

Insys Therapeutics aims to take the rough edges off of chemo and cancer pain. The drug development company is focused on treating side effects of chemotherapy, as well as therapies for pain management. Its lead candidate is a fast-acting oral spray version of cancer pain drug Fentanyl. Its Dronabinol candidate is a generic capsule form of Marinol (a synthetic version of the active chemical in marijuana) for treatment of chemotherapy-induced nausea and vomiting. Both drugs are in late stage development awaiting FDA approval. All of the company's drug candidates are... More

Work at Insys Therapeutics? Share Your Experiences

Insys Therapeutics

 
Click to Rate
or